Authors:
Peters, K
Leitzke, S
Diederichs, JE
Borner, K
Hahn, H
Muller, RH
Ehlers, S
Citation: K. Peters et al., Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection, J ANTIMICRO, 45(1), 2000, pp. 77-83
Authors:
Scholer, N
Zimmermann, E
Katzfey, U
Hahn, H
Muller, RH
Liesenfeld, O
Citation: N. Scholer et al., Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages, J MICROENC, 17(5), 2000, pp. 639-650
Authors:
Simon, D
Muller, RH
Grosse, HJ
Bley, T
Babel, W
Citation: D. Simon et al., Response of Ralstonia eutropha JMP 134 to long-term exposure to toxic substrates in nutristat cultivation as indicated by on-line fluorescence measurements, BIOPROC ENG, 23(1), 2000, pp. 1-10
Citation: A. Gessner et al., Analysis of plasma protein adsorption onto polystyrene particles by two-dimensional electrophoresis: Comparison of sample application and isoelectricfocusing techniques, ELECTROPHOR, 21(12), 2000, pp. 2438-2442
Citation: Rh. Muller et W. Babel, A theoretical study on the metabolic requirements resulting from alpha-ketoglutarate-dependent cleavage of phenoxyalkanoates, APPL ENVIR, 66(1), 2000, pp. 339-344
Citation: Bhl. Bohm et Rh. Muller, Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs, PHARM SCI T, 2(8), 1999, pp. 336-339
Authors:
Muller, RH
Jorks, S
Kleinsteuber, S
Babel, W
Citation: Rh. Muller et al., Comamonas acidovorans strain MC1: a new isolate capable of degrading the chiral herbicides dichlorprop and mecoprop and the herbicides 2,4-D and MCPA, MICROBI RES, 154(3), 1999, pp. 241-246
Authors:
Borner, K
Hartwig, H
Leitzke, S
Hahn, H
Muller, RH
Ehlers, S
Citation: K. Borner et al., HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations, INT J ANT A, 11(1), 1999, pp. 75-79
Citation: K. Peters et al., An investigation into the distribution of lecithins in nanosuspension systems using low frequency dielectric spectroscopy, INT J PHARM, 184(1), 1999, pp. 53-61
Citation: C. Freitas et Rh. Muller, Stability determination of solid lipid nanoparticles (SLN (TM)) in aqueousdispersion after addition of electrolyte, J MICROENC, 16(1), 1999, pp. 59-71
Authors:
Luck, M
Schroder, W
Paulke, BR
Blunk, T
Muller, RH
Citation: M. Luck et al., Complement activation by model drug carriers for intravenous application: determination by two-dimensional electrophoresis, BIOMATERIAL, 20(21), 1999, pp. 2063-2068
Authors:
Peracchia, MT
Harnisch, S
Pinto-Alphandary, H
Gulik, A
Dedieu, JC
Desmaele, D
d'Angelo, J
Muller, RH
Couvreur, P
Citation: Mt. Peracchia et al., Visualization of in vitro protein-rejecting properties of PEGylated stealth (R) polycyanoacrylate nanoparticles, BIOMATERIAL, 20(14), 1999, pp. 1269-1275
Citation: Rh. Muller et W. Babel, Separation of two dichlorprop/alpha-ketoglutarate dioxygenases with enantiospecific properties from Comamonas acidovorans MC1, ACT BIOTECH, 19(4), 1999, pp. 349-355
Citation: Jf. Pinto et Rh. Muller, Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugs, PHARMAZIE, 54(7), 1999, pp. 506-509
Citation: A. Radomska et al., Chemical stability of the lipid matrices of solid lipid nanoparticles (SLN)-development of an analytical method and determination of long-term stability, PHARMAZIE, 54(12), 1999, pp. 903-909